Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesBart L. Scott, Mitchell E. Horwitz, Hugo F. Fernández et al.|Journal of Clinical Oncology|2017Cited by 664
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantationJohn R. Wingard, Kieren A. Marr, Shelly L. Carter et al.|Blood|2010Cited by 477
Comparative Outcomes of Donor Graft CD34<sup>+</sup> Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell TransplantationMarcelo C. Pasquini, Robert J. Soiffer, Steven M. Devine et al.|Journal of Clinical Oncology|2012Cited by 157
Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients.John R. Wingard, Kieren A. Marr, Shelly L. Carter et al.|Blood|2007Cited by 91